76 related articles for article (PubMed ID: 17678926)
1. Chronic proton pump inhibitor therapy and the risk of colorectal cancer.
Yang YX; Hennessy S; Propert K; Hwang WT; Sedarat A; Lewis JD
Gastroenterology; 2007 Sep; 133(3):748-54. PubMed ID: 17678926
[TBL] [Abstract][Full Text] [Related]
2. Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study.
Arana A; Johannes CB; McQuay LJ; Varas-Lorenzo C; Fife D; Rothman KJ
Drug Saf; 2015 Dec; 38(12):1187-99. PubMed ID: 26350642
[TBL] [Abstract][Full Text] [Related]
3. Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case-control studies.
Vinogradova Y; Coupland C; Hippisley-Cox J
Br J Cancer; 2011 Jul; 105(3):452-9. PubMed ID: 21750557
[TBL] [Abstract][Full Text] [Related]
4. Association between Parkinson's disease and proton pump inhibitors therapy in older people.
Lai SW; Liao KF; Lin CL; Lin CH
Biomedicine (Taipei); 2020; 10(3):1-4. PubMed ID: 33854921
[TBL] [Abstract][Full Text] [Related]
5. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database.
Langman MJ; Cheng KK; Gilman EA; Lancashire RJ
BMJ; 2000 Jun; 320(7250):1642-6. PubMed ID: 10856067
[TBL] [Abstract][Full Text] [Related]
6. Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor.
Wu CY; Ho HJ; Wu CY; Chen YJ; Lee TY; Hsu YC; Lin JT
Gut; 2020 Sep; ():. PubMed ID: 32907829
[No Abstract] [Full Text] [Related]
7. Altered Microbial Transcription in Long-term Proton Pump Inhibitor Use: Findings From a United States Cohort Study.
Kim H; Nzabarushimana E; Huttenhower C; Chan AT; Nguyen LH
Gastroenterology; 2024 Mar; ():. PubMed ID: 38521094
[No Abstract] [Full Text] [Related]
8. The association between proton pump inhibitor use and systemic anti-tumour therapy on survival outcomes in patients with advanced non-small cell lung cancer: A systematic review and meta-analysis.
Br J Clin Pharmacol; 2024 May; 90(5):1371. PubMed ID: 38570720
[No Abstract] [Full Text] [Related]
9. Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations.
Kamboj AK; Patel DA; Yadlapati R
Clin Gastroenterol Hepatol; 2024 Mar; ():. PubMed ID: 38471653
[No Abstract] [Full Text] [Related]
10. Increased Risk of Serious Infection with Proton Pump Inhibitor Use in Children.
Rosenberg K
Am J Nurs; 2023 Nov; 123(11):62. PubMed ID: 37882409
[TBL] [Abstract][Full Text] [Related]
11. Analysis and evaluation of outpatient proton pump inhibitor utilization and irrational drug use in our hospital from 2021 to 2023.
Liu H; Guo C; Tong C; Chen G; Tao Y; Ren F
Panminerva Med; 2024 Feb; ():. PubMed ID: 38305011
[No Abstract] [Full Text] [Related]
12. Questionable Safety of Proton Pump Inhibitor Use in Children.
Berry JG; Mansbach JM
JAMA Pediatr; 2023 Oct; 177(10):1010-1012. PubMed ID: 37578788
[No Abstract] [Full Text] [Related]
13. Proton pump inhibitors and the risk of colorectal cancer.
van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ
Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population.
Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA
Am J Gastroenterol; 2020 May; 115(5):706-715. PubMed ID: 32205645
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitors and Likelihood of Colorectal Cancer in the Korean Population: Insights from a Nested Case-Control Study Using National Health Insurance Data.
Kwon MJ; Han KM; Kim JH; Kim JH; Kim MJ; Kim NY; Choi HG; Kang HS
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067310
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer.
Wu CC; Fang CY; Yu BH; Chang CM; Hsu TW; Hung CL; Hung SK; Chiou WY; Tsai JH
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958477
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Proton Pump Inhibitor Use on Survival of Patients With Colorectal Cancer: A Study of a Racially Diverse Population.
Obeidat AE; Monti G; Choi H; Acoba J
Cureus; 2023 May; 15(5):e38707. PubMed ID: 37292522
[TBL] [Abstract][Full Text] [Related]
18. Association of proton pump inhibitors with gastric and colorectal cancer risk: A systematic review and meta-analysis.
Guo H; Zhang R; Zhang P; Chen Z; Hua Y; Huang X; Li X
Front Pharmacol; 2023; 14():1129948. PubMed ID: 37007006
[No Abstract] [Full Text] [Related]
19. Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs-Updated Review.
Mruk-Mazurkiewicz H; Kulaszyńska M; Jakubczyk K; Janda-Milczarek K; Czarnecka W; Rębacz-Maron E; Zacha S; Sieńko J; Zeair S; Dalewski B; Marlicz W; Łoniewski I; Skonieczna-Żydecka K
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979931
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
